A detailed history of Sterling Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Sterling Financial Group, Inc. holds 366 shares of LLY stock, worth $309,939. This represents 0.18% of its overall portfolio holdings.

Number of Shares
366
Previous 361 1.39%
Holding current value
$309,939
Previous $326,000 0.61%
% of portfolio
0.18%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $3,860 - $4,800
5 Added 1.39%
366 $324,000
Q1 2024

Apr 10, 2024

BUY
$592.2 - $792.28 $2,368 - $3,169
4 Added 1.12%
361 $280,000
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $187,492 - $221,029
357 New
357 $208,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sterling Financial Group, Inc. Portfolio

Follow Sterling Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Financial Group, Inc. with notifications on news.